Showing results (241-250 of 308) with videos related to

Sort By:
Pageof 31
Parkinsonism & Related Disorders|May 16, 2018
Entacapone and prostate cancer in Parkinson's disease patients: A large Veterans Affairs healthcare system studyJacqueline M Major, Diane Dong, Francesca Cunningham, et al.
JAMA Network Open|September 30, 2020
Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin LevelsJuan P Brito, Joseph S Ross, Lindsey Sangaralingham, et al.
Pharmacoepidemiology and Drug Safety|February 3, 2021
Trends in Erythropoiesis-stimulating agent use and blood transfusions for chemotherapy-induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycleAmarilys Vega, Rongmei Zhang, Hui-Lee Wong, et al.
ANZ Journal of Surgery|August 26, 2021
Correlation of magnetic resonance and arthroscopy in the diagnosis of shoulder injuryPatrick Groarke, Simond Jagernauth, Susan E Peters, et al.
American Journal of Preventive Medicine|June 14, 2025
Cannabis-related healthcare encounters among U.S. commercially insured adultsSilvia Perez-Vilar, Sruthi Adimadhyam, Jillian Burk, et al.
Endocrine|June 5, 2021
Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine useJuan P Brito, Joseph S Ross, Yihong Deng, et al.
American Heart Journal|March 9, 2023
Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning methodChe Ngufor, Xiaoxi Yao, Jonathan W Inselman, et al.
Circulation|November 1, 2014
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillationDavid J Graham, Marsha E Reichman, Michael Wernecke, et al.
The American Journal of Psychiatry|June 15, 2022
Mortality Among Parkinson's Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare BeneficiariesAndrew D Mosholder, Yong Ma, Sandia Akhtar, et al.
The American Journal of Medicine|January 15, 2019
Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial FibrillationDavid J Graham, Elande Baro, Rongmei Zhang, et al.
Pageof 31